Introduction {#s1}
============

Sensory-motor circuits within the spinal cord are essential for the coordinated control of limb muscle. In mammals, proprioceptive sensory neurons (pSN) process a continuous stream of data from approximately 50 forelimb or hindlimb muscles, and relay this information to the appropriate circuits tasked to orchestrate motor behaviors ([@bib32]; [@bib64]). The orderly arrangement of connections formed between pSNs and spinal circuits enable animals to seamlessly perform a vast repertoire of limb movements. A single pool of motor neurons (MNs) innervates an individual muscle and receives instructive feedback, not only from sensory neurons, but also descending inputs from supraspinal centers and local spinal interneurons ([@bib3]; [@bib56]). These inputs collectively modify the pattern of MN activity thereby choreographing appropriate muscle activation sequences during behavior.

The simplest input pathway to MNs is the monosynaptic reflex arc, composed of a limb muscle innervated by a pool of alpha MNs and type Ia pSNs with stretch-sensing mechanoreceptor endings embedded within muscle spindles. Type Ia pSNs are uniquely poised to provide direct and immediate muscle status information through the monosynaptic connections they establish with MNs. During development, pSN axons navigate through the spinal cord, preferentially contacting MN pools innervating the same peripheral target, while avoiding MNs of functionally antagonist muscles ([@bib25]; [@bib44]). These connections are remarkably selective, as a single pSN establishes monosynaptic connections with each of the \~50--300 MNs that supply the same muscle target ([@bib45]). While the mechanisms of pSN central specificity are largely unknown, they appear to be established independent of patterned neural activity ([@bib46]; [@bib47]), suggesting pSN-MN matching relies on genetic programs acting during neural development.

After sensory neurons are born, nascent neurons advance through a hierarchical process of diversification in which expression of specific genes coincides with the acquisition of specialized neuronal characteristics, including peripheral target specificity and central projection pattern ([@bib21]; [@bib39]). Sensory neurons generated at spinal levels derive from neural crest cells which coalesce outside the CNS to form dorsal root ganglia (DRG) ([@bib14]). As DRG develop, most sensory neurons co-express the homeodomain transcription factors Isl1 and Brn3a, which are necessary for deployment of pan-sensory neuron genetic programs ([@bib24]). At these early stages, pSNs can be discriminated from other sensory classes by expression of the transcription factors Runx3 and Etv1, the neurotrophin receptor *Nrtk3*, and the calcium binding protein Parvalbumin (PV). Genetic studies in mice indicate that *Runx3* and *Etv1* are essential for establishing and maintaining core features of pSN identity, including their survival and ability to extend central axons into the ventral spinal cord ([@bib2]; [@bib33]).

While the transcriptional programs governing features common to all pSNs have been characterized, understanding later developmental facets of sensory neuron specification, such as muscle target specificity and central connectivity, has been particularly challenging. In contrast to the topographic arrangement of spinal MN subtypes, sensory neurons of different modalities and attributes are intermixed within a DRG, with no clear organizational pattern, aside from restricted expression of early determinants involved in establishing a broader sensory neuron class identity ([@bib31]; [@bib34]). A dearth of molecular markers for more nuanced neuronal features has made it challenging to characterize how pSNs and other sensory modalities further diversify into specific subtypes. One particular gap in our understanding is how the specificity of central connections between pSNs and MNs of the same muscle is achieved, since pSN axons must distinguish between vast numbers of potential postsynaptic targets within the ventral spinal cord.

A significant contributing factor to the specificity of connections in sensory-motor circuits is the recognition of specific MN subtypes by pSN central afferents. As the limb develops, a network of \~20 Hox transcription factors determines the molecular identities and peripheral target specificities of lateral motor column (LMC) neurons dedicated to limb control ([@bib54]). Mutation in genes acting downstream of Hox function in MNs, including the transcription factor *Pea3* and synaptic-specificity determinant *Sema3e*, leads to a disruption in the normal pattern of central connections between pSN and MNs ([@bib27]; [@bib53]; [@bib65]). In addition, genetic transformation of thoracic MNs to a limb-level LMC fate, through mutation in the *Hoxc9* gene, results in the formation of ectopic synaptic connections between limb pSNs and axial muscle-innervating MNs ([@bib5]). By contrast, after MN-specific deletion of the *Foxp1* gene, which encodes a factor required for all Hox activity in limb MNs, pSN axons maintain appropriate termination patterns within the ventral spinal cord ([@bib59]). However, because MN topographic organization is scrambled in *Foxp1* mutants, limb pSNs form connections with inappropriate MN subtypes. The preservation of pSN central projection pattern in *Foxp1* mutants suggests pSNs acquire specific features that enable them to target specific dorsoventral domains within the spinal cord.

While studies provide evidence for an essential role for MN subtype identity in establishing sensory-motor synaptic specificity, the mechanisms that determine the central pattern of pSN postsynaptic connections are poorly understood. In contrast to MN specification, where key developmental features emerge largely independent of peripheral cues, sensory neuron development relies on extrinsic signals provided by limb mesenchyme and muscle ([@bib3]; [@bib58]; [@bib69]). Expression of the *Nrtk3* receptor renders pSNs sensitive to peripheral neurotrophin-3 (*Ntf3*) signaling, and both *Nrtk3* and *Ntf3* are essential for the differentiation and survival of pSNs ([@bib18]). *Ntf3*/*Nrtk3* signaling regulates expression of *Etv1* and *Runx3*, and muscle-by-muscle differences in the level of *Ntf3* expression appear to contribute to pSN subtype diversity ([@bib22]; [@bib52]; [@bib66]). Moreover, it has been shown that signals originating from the limb mesenchyme can trigger expression of genes that mark muscle-specific pSN subtypes ([@bib57]). While certain molecular features common to all pSNs have been shown to be limb-independent ([@bib17]), whether pSN diversity and synaptic specificity rely on neuronal-intrinsic specification programs remain to be determined. As such there are currently no known fate determinants of muscle-specific pSNs.

We considered the possibility that the same Hox-dependent regulatory networks employed to specify spinal MN subtypes also contribute to the diversification of pSNs during sensory-motor circuit assembly. We show that selective expression of Hox proteins defines pSN populations generated at specific rostrocaudal levels, paralleling Hox expression in spinal MNs. Expression of *Hox* genes is maintained in both pSNs and MNs after removal of the developing limb bud, indicating that neuronal *Hox* pattern is initially established independent of target-derived cues. We found that distal forelimb flexor muscles, and the MNs that innervate them, are targeted by pSNs expressing the *Hoxc8* gene. In the absence of *Hoxc8* function, forelimb pSNs establish ectopic monosynaptic contacts on MNs innervating functionally antagonist forelimb muscles. These studies provide evidence for a neuronal-intrinsic program in which the selective activities of Hox proteins encodes key features of pSN diversification and target selectivity.

Results {#s2}
=======

*Hox* expression delineates subpopulations of pSNs along the rostrocaudal axis {#s2-1}
------------------------------------------------------------------------------

To explore a potential role for *Hox* genes in pSN diversification, we analyzed the expression of individual Hox proteins in spinal DRG during the early phases of sensory neuron development ([Figure 1](#fig1){ref-type="fig"}). We examined Hox protein expression in relation to Runx3, Etv1, and PV, three markers predominately restricted to pSN subtypes. Because the patterns of *Hox* gene expression within the spinal cord are most thoroughly characterized in cervical (C) segments ([@bib16]; [@bib38]), we focused on the pattern of *Hox* expression in DRG generated between C2-C8. We began by analyzing the DRG expression of a subset of *Hox4-Hox8* paralog genes between E12.5-E14.5, stages in which pSN axons have reached their muscle targets and central afferents have begun to invade the dorsal spinal cord ([@bib29]; [@bib37]). We found that subpopulations of cervical DRG neurons selectively coexpressed Hox proteins and molecular markers of pSN identity ([Figure 1](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Hox proteins expressed by pSNs included Hoxc4, Hoxa5, Hoxc6, Hoxa7, and Hoxc8, which also collectively define forelimb LMC neuron diversity ([Figure 1a--e](#fig1){ref-type="fig"}; [@bib20]). Each of these Hox proteins were detected at cervical levels and/or rostral thoracic segments, but were not present in caudal thoracic or lumbar DRG (data not shown). Within individual cervical DRG, Hox proteins were expressed by a subset of pSNs, and the fraction of pSNs expressing a given *Hox* gene within a single DRG varied along the rostrocaudal axis ([Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). Interestingly, members of the *Hoxb* gene cluster, including *Hoxb4*, were also restricted to cervical segments, but appeared to be more broadly expressed by DRG classes ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"}, data not shown). These observations indicate that members of the *Hoxa* and *Hoxc* gene clusters are expressed by subsets of cervical pSNs.

![Restricted *Hox* expression defines pSN subtype identity.\
(**a--e**) Expression of indicated Hox proteins in cervical DRG. Images show cross sections of DRG located between segmental levels C2-C8 of E14.5 mouse embryos stained with Hox and the pSN markers PV or Etv1. Images are representative of at least three embryos analyzed at this age. (**f**) Coexpression of Hoxc6 and Hoxc8 in subsets of pSNs in caudal cervical DRG. (**g**) Coexpression of Hoxc8 and Hoxa7 in sensory neurons. (**h**) Meis2 coexpression with PV in sensory neurons. (**i**) Top-down view of E13.5 mouse spinal cord showing mutually exclusive expression of Hoxa5 and Hoxc8 in DRG. Spinal MNs also abide by restricted rostrocaudal domains of Hoxa5 and Hoxc8 expression. (**j**) Summary of Hoxa5 and Hoxc8 expression pattern in MNs and pSNs. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-56374-fig1){#fig1}

###### Expression of *Hox4-Hox8* paralog proteins in SNs.

Table lists each of the tetrapod *Hox4-Hox8* gene paralogs and their expression pattern in SNs between segmental levels CII-TII. Not all antibody combinations were tested for Hox co-expression. ND, not detected; NT, not tested.

  Hox protein   DRG expression   pSN expression   RC level    Hox co-expression
  ------------- ---------------- ---------------- ----------- -------------------
  Hoxc4         yes              yes              CII-CVII    Hoxa5
   Hoxc5        NT               \-               \-          \-
  Hoxc6         yes              yes              CIV-CVIII   Hoxc8
  Hoxc8         yes              yes              CVI-TII     Hoxc6, Hoxa7
   Hoxa4        NT               \-               \-          \-
  Hoxa5         yes              yes              CII-CVI     Hoxc4
   Hoxa6        ND               \-               \-          \-
  Hoxa7         yes              yes              CV-TII      Hoxc8
   Hoxb4        yes              no               NT          \-
   Hoxb5        yes              no               NT          \-
   Hoxb6        NT               \-               \-          \-
   Hoxb7        NT               \-               \-          \-
   Hoxb8        NT               \-               \-          \-
   Hoxd4        NT               \-               \-          \-

Within a single DRG, a proportion of pSNs also demonstrated co-expression of multiple Hox proteins. For example, within individual cervical DRG, a subset of Hoxc8^+^ cells coexpressed Hoxa7, a subset of Hoxa5^+^ pSNs co-expressed Hoxc4, and a subset of Hoxc6^+^ pSNs expressed Hoxc8 ([Figure 1f,g](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}). Furthermore, DNA-binding cofactors known to be essential for Hox activity ([@bib49]), including Meis2 and Pbx3, were detected in pSNs ([Figure 1h](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). Both Meis2 and Pbx3 were expressed by pSNs but also observed in non-proprioceptive sensory neuron subtypes, and lacked rostrocaudal specificity. These observations suggest that the combinatorial actions of Hox proteins and their co-factors could account for subtype diversity of cervical pSNs.

We next compared the expression of individual *Hox* genes in sensory neurons along the rostrocaudal axis of the spinal cord. While certain *Hox* genes are coexpressed within the same sensory neuron, others demonstrate clear boundaries from one another and do not co-localize, despite being expressed in the same sensory class. For example, Hoxa5 expression was confined to pSNs in rostral cervical segments (C2-C5) while Hoxc8 expression was restricted to caudal cervical and rostral thoracic DRG (C6 to T2) ([Figure 1i,j](#fig1){ref-type="fig"}). Thus, Hoxa5 and Hoxc8 expression by pSNs is mutually exclusive and mirrors the restricted expression pattern of Hoxa5/Hoxc8 in forelimb-innervating MNs. These observations indicate that pSN subtypes can be delineated by differential *Hox* gene expression, and suggest that pSNs employ early rostrocaudal patterning mechanisms similar to those of MNs.

Neuronal expression of *Hox* genes is initially limb-independent {#s2-2}
----------------------------------------------------------------

During the early stages of neural tube development, expression of *Hox* genes is initiated by secreted morphogens acting on progenitors along the rostrocaudal axis ([@bib9]; [@bib19]; [@bib42]). These early patterning signals induce *Hox* expression in the neural tube prior to limb bud formation. By contrast, studies of limb and non-limb innervating pSNs have shown that the molecular identities and central projection patterns of pSNs are established and maintained through extrinsic, target-derived, signals ([@bib22]; [@bib57]). These findings raise the question of what the relative contributions of early patterning signals and target-derived cues are in regulating *Hox* expression in pSNs.

To answer this question, we used limb-bud ablation assays in chick embryos to determine whether *Hox* expression in pSNs persists after removal of signals provided by limb mesenchyme and muscle. We first examined whether the expression of Hox proteins in sensory neurons is conserved between mouse and chick. We found that Hoxa5, Hoxc6, and Hoxc8 were selectively expressed by forelimb-level DRG by st31 (equivalent to E13.5 in mouse) ([Figure 2a,b](#fig2){ref-type="fig"}). As in mouse DRG, Hoxa5 was expressed by rostral cervical DRG, Hoxc8 was expressed by caudal cervical sensory neurons, while Hoxc6 was expressed in both rostral and caudal cervical DRG ([Figure 2a,b](#fig2){ref-type="fig"}). Co-staining with the pSN-restricted marker Runx3 indicated that Hox proteins are expressed by pSNs in chick, with some notable differences from mouse. In chick, Hoxa5 was broadly expressed by rostral cervical sensory neurons, while Hoxc8 was detected in a smaller fraction of caudal cervical pSNs ([Figure 2---figure supplement 1a--c](#fig2s1){ref-type="fig"}). The reduced number of Hoxc8^+^ pSNs in chick versus mouse likely reflect evolutionary changes in the distribution and function of avian and rodent forelimb muscle.

![Limb-independent expression of *Hox* genes in sensory neurons.\
(**a and b**) Expression of Hoxa5, Hoxc6, and Hoxc8 in chick forelimb level DRG shown with pan-sensory neuron marker Islet1 (Isl1). Images show cross sections of chick DRG at \~St 26. Hoxa5 and Hoxc6 are present at rostral cervical segments while Hoxc8 is absent from this region (**a**). Hoxa5 is not found in caudal cervical DRG whereas Hoxc6 and Hoxc8 are present within this region (**b**). Images are representative of at least three embryos analyzed at this age. (**c**) Unilateral forelimb bud ablation of chick at St 16--18. Embryos harvested at St 26--28. (**d--e**) Loss of Pea3 expression on the limb-ablated side in relation to the non-ablated side. Expression of Isl1 is unaffected at this stage. Images show cervical DRG of an individual embryo at the same segmental levels between ablated and non-ablated sides for each panel. (**f**) Quantification of loss of Pea3, as a fraction of total Isl1^+^ SNs. Controls, 31.8 ± 3.6%, N = 12 sections from three animals, ablated 5.5 ± 0.1%, N = 12 sections from three animals, p\<0.0001, Student's t-test. (**g--i**) Top panels show expression of individual Hox expression. Bottom panels show Hox expression with Isl1. There is no difference in Hox expression between the ablated and non-ablated side for Hoxa5^+^ SNs in rostral cervical segments (**g**), Hoxc6^+^ SNs in rostral and caudal cervical segments (**h**), or Hoxc8^+^ SNs in caudal cervical segments (**i**). (**j--k**) Quantification of fraction of Hox^+^Isl1^+^ over total Isl1^+^ SNs in control and limb-ablated chick embryos. For each Hox protein, sections were obtained from three limb-ablated embryos, with non-ablated side of embryo serving as the control. Hoxa5 (44.3 ± 4.7% in N = 11 control sections, 50.7 ± 3.2% in N = 11 limb-ablated sections, p=0.27, Student's t-test), Hoxc6 (26.8 ± 2.0% in N = 15 control sections, 26.3 ± 3.0% in N = 13 limb-ablated sections, p=0.90), and Hoxc8 (6.4 ± 0.9% in N = 7 control sections, 7.6 ± 0.8% in N = 8 sections ablated, p=0.32). See also [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.\
Figure 2---source data 1.Quantification of markers proteins after limb bud ablation.](elife-56374-fig2){#fig2}

We next unilaterally ablated the forelimb bud of chick embryos at stage (St) 16--18, a phase when the initial rostrocaudal profiles of *Hox* gene expression have been established, but prior to the appearance of postmitotic pSNs and MNs (\~E8.5 in mouse) ([Figure 2c](#fig2){ref-type="fig"}). After limb bud extirpation, embryos were allowed to continue to develop for 3 days (to \~st26-28 \[\~E11.5-12.5 in mouse\]). At this age, all MNs and pSNs have been generated, but have not reached the phase where they rely on limb-derived neurotrophic support. To confirm successful removal of limb-derived cues, we examined expression of the ETS protein Pea3, which is expressed by subsets of pSNs and MNs in a limb-dependent manner ([@bib41]). After forelimb bud ablation, the number of sensory neurons and MNs expressing Pea3 markedly decreased relative to the non-ablated side ([Figure 2e](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1e](#fig2s1){ref-type="fig"}). The fraction of Isl1^+^ SNs expressing Pea3 was reduced to 5.5 ± 0.1% (mean ± SEM), compared to 31.8 ± 3.6% in controls (p\<0.0001, Student's t-test) ([Figure 2f](#fig2){ref-type="fig"}). In addition, the number of SNs expressing Runx3 was reduced from 15.5 ± 2.4% in controls to 7.3 ± 0.9% after limb ablation (p=0.0038, Student's t-test) ([Figure 2---figure supplement 1d](#fig2s1){ref-type="fig"}). The decrease in Pea3 expression was not a result of the general loss of sensory neurons as the number of Isl1^+^ DRG neurons, a pan-sensory neuron marker, was comparable between the ipsilateral and contralateral sides of the ablated limb ([Figure 2e](#fig2){ref-type="fig"}).

In contrast to the loss of Pea3, expression of Hoxa5, Hoxc6, and Hoxc8 were unchanged in both sensory neurons and MNs after forelimb removal ([Figure 2g--i](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1a--c,e--g](#fig2s1){ref-type="fig"}). The fraction of Isl1^+^ SNs expressing Hoxa5 (44.3 ± 4.7% in controls, 50.7 ± 3.2% ablated, p=0.27, Student's t-test), Hoxc6 (26.8 ± 2.0% controls, 26.3 ± 3.0% ablated, p=0.90), and Hoxc8 (6.4 ± 0.9% controls, 7.6 ± 0.8% ablated, p=0.32) was not significantly changed ([Figure 2j,k,l](#fig2){ref-type="fig"}). Because expression of the pSN markers Runx3 and Etv1 are reduced after limb ablation, we were unable to quantify the fraction of pSNs that retain Hox expression. Nevertheless, these results are consistent with a model in which the pattern of *Hox* gene expression in sensory neurons and MNs is initiated through intrinsic genetic programs that operate independent of limb-derived cues.

Hoxc8 expression in type-Ia pSNs during sensory-motor circuit maturation {#s2-3}
------------------------------------------------------------------------

To further examine contribution of *Hox* genes to the diversification of sensory neuron subtypes, we performed a detailed characterization of Hox protein expression in relation to the ontogeny of sensory-motor circuit development ([Figure 3](#fig3){ref-type="fig"}). We focused our studies on *Hoxc8* for this analysis, due to its central role in establishing the molecular identities and muscle-target specificity of MNs innervating distal forelimb muscles of mouse and chick ([@bib16]; [@bib20]).

![Profile of *Hoxc8* in pSNs during sensory-motor circuit development.\
(**a, b**) Expression of Hoxc8 with the pSN marker Runx3 at E11.5 (**a**) and E12.5 (**b**). (**c**) Hoxc8 and Etv1 expression in pSNs at E15.5. (**d**) Colocalization of Hoxc8 and βGal in *PLAT::Cre; Hoxc8^LacZ-flox/+^* mice at E14.5. (**e, f**) Colocalization of βGal with the pSN marker PV at E18 (**e**) and P8 (**f**). (**g**) Quantification of Hoxc8 with either Etv1 or PV at E14.5. Each data point shows individual sections taken from at least three mice. Hoxc8^+^Etv1^+^/total Hoxc8^+ ^cells = 0.95 ± 0.01 (mean ± SEM, N = 30 sections); Hoxc8^+^Etv1^+^/total Etv1^+ ^cells = 0.82 ± 0.01 (N = 30 sections); Hoxc8^+^PV^+^/total Hoxc8^+ ^cells = 0.91 ± 0.02 (N = 28 sections); Hoxc8^+^PV^+^/total PV^+ ^cells = 0.50 ± 0.04 (N = 28 sections). (**h**) Non-overlapping expression of βGal and Ret, a marker for subpopulations of cutaneous sensory neurons at E16.5. See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.\
Figure 3---source data 1.Quanification of marker proteins in sensory neurons.](elife-56374-fig3){#fig3}

To determine at which phase of sensory-motor circuit development *Hoxc8* might be required, we analyzed the ontogeny of Hoxc8 protein expression in pSNs in mouse. Since the levels of Hoxc8 protein expression in the CNS attenuate at later stages of embryonic development, we utilized a conditional *Hoxc8* allele in which a *LacZ* reporter is expressed upon Cre-dependent excision of *Hoxc8* coding sequence ([@bib12]; [@bib16]). To achieve sensory neuron-restricted *LacZ* reporter expression, we crossed *Hoxc8^LacZ-flox/+^* mice to an *PLAT::Cre* line. This line drives Cre expression in the neural crest cells from which spinal sensory neurons are derived, but is excluded from neurons in the central nervous system ([@bib55]). This breeding strategy allowed us to unambiguously identify Hoxc8^+^ pSNs at later postnatal stages, due to the persistence of βGal protein expression. At E14.5-E15.5 all βGal positive cells expressed Hoxc8 and Runx3 proteins ([Figure 3d](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1d,e](#fig3s1){ref-type="fig"}), indicating this strategy recapitulates the normal pattern of *Hoxc8* expression in pSNs.

Presumptive pSNs initiate Hoxc8 protein expression at E11.5, shortly after the appearance of postmitotic sensory neurons ([Figure 3a](#fig3){ref-type="fig"}). Hoxc8 is maintained between E12.5 and E15.5, the time window in which pSNs extend axons to their peripheral muscle targets and central afferents begin to enter the dorsal spinal cord ([Figure 3b,c](#fig3){ref-type="fig"}). Hoxc8 and βGal continued to be expressed through the first postnatal week, during the phase in which pSNs extend central projections within the ventral spinal cord and connect with central postsynaptic targets ([Figure 3e,f](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Therefore, based on our analysis, expression of Hoxc8 coincides with the period of embryonic development when forelimb-innervating pSNs begin forming connections with their peripheral muscle and central postsynaptic targets.

To further confirm the specificity of Hoxc8 in pSNs we examined its expression in relation to Etv1 and PV between segmental levels C6-T1 at E14.5. The majority (\>90%) of Hoxc8^+^ neurons expressed Etv1 and PV, consistent with a pSN-restricted expression pattern ([Figure 3g](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1a,b](#fig3s1){ref-type="fig"}). At these segmental levels, however, Hoxc8 was expressed by only \~50% of the total PV^+^ population ([Figure 3g](#fig3){ref-type="fig"}). Between segments C6-C8, 15--20% of PV^+^ sensory neurons have been shown to co-express Ret, a marker for a subset of cutaneous sensory neurons ([@bib50]). We found that all Hoxc8^+^ sensory neurons lacked Ret expression. These results indicate a fraction of cervical pSNs express Hoxc8, but that cervical PV^+^Ret^+^ sensory neurons, likely cutaneous sensory neurons, are Hoxc8^-^ ([Figure 3g,h](#fig3){ref-type="fig"}).

Peripheral muscle target specificity of Hoxc8^+^ pSNs {#s2-4}
-----------------------------------------------------

In spinal MNs, the profile of Hox expression along the rostrocaudal axis is correlated with the position of muscles along the proximal-distal and anterior-posterior axes of the limb. Rostral cervical Hoxa5^+^ LMC neurons typically innervate more anterior/proximal forelimb muscles, while caudal cervical Hoxc8^+^ MNs project to distally and/or posteriorly located forelimb muscles ([@bib16]). Because the rostrocaudal profile of *Hox* genes in pSNs mirrors that of spinal MNs, and Hoxc8^+^ MNs are known to innervate distal forelimb muscles, we sought to evaluate muscle target selectivity of Hoxc8^+^ pSNs.

To identify the peripheral muscle targets of Hoxc8^+^ pSNs, we labeled pSNs through intramuscular injection of Cholera toxin B subunit (CTB) and examined Hoxc8/βGal protein expression in retrogradely labeled neurons. We performed retrograde tracing assays on nine specific forelimb muscles, ranging from proximal to distal positions, and varying in size, but sharing a common role in controlling arm, wrist, or digit movement ([Figure 4a](#fig4){ref-type="fig"}). In the distal forelimb, flexor muscles are positioned ventrally and act to adduct the wrist and flex the digits. Conversely, distal extensor muscles reside dorsally and act as antagonists to distal flexors. Although each of the major forelimb-controlling muscles were injected and processed for analysis, a few were excluded due to inaccessibility, as deeper muscles would require the removal of the overlying musculature. CTB was injected into single forelimb muscles of wildtype and *PLAT::Cre; Hoxc8^LacZ-flox/+^* mice at P4, thereby retrogradely labeling sensory neuron afferent fibers that have taken up CTB tracer through direct contact with muscle (N ≥ 3 animals/muscle). Spinal cords with attached DRG were then isolated at P7 to assess representative populations of sensory neurons innervating the injected muscle. Injections were performed no earlier than P4 due to the thin size of the distal forelimb muscles as well as the inefficiency of neonatal CTB labeling, a probable outcome of lower expression levels of the CTB receptor in neonates ([@bib70]). The coincidence of CTB/Hoxc8/PV and CTB/βGal/PV labeling was then analyzed in DRG to determine if the muscle received innervation from Hoxc8^+^ pSNs.

![Hoxc8 pSNs preferentially target distal flexor limb muscles.\
(**a**) Schematic of distal forelimb muscles of mouse. Limb flexor muscles shown in orange, extensors in purple. Muscles were injected with CTB at P4 and collected at P7. (**b--j**) Cross sections of caudal cervical DRG of *PLAT::Cre; Hoxc8^LacZ-flox/+^* mice injected with CTB in an individual forelimb muscle. First column shows colocalization of Hoxc8, CTB, and PV; second column colocalization of βGal, CTB, and PV; and third column βGal and CTB. (**k**) Table of injected forelimb muscles with quantification of βGal^+^ pSN innervation shown as percentage (βGal^+^CTB ^+^ PV^+^ SNs over total CTB^+^PV^+^SNs in all sections) with raw numbers next to percentages. Values in table show cumulative data from CTB-labeled DRG sections collected from at least three mice per muscle. See also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.](elife-56374-fig4){#fig4}

With the exception of the biceps brachii, all of the injected flexor muscles were found to be innervated by predominately Hoxc8^+^ pSNs, including the pectoralis major (PM), flexor carpi ulnaris (FCU), palmaris longus (PL), and flexor digitorum profundus (FDP). For the PM, FCU, PL, and FDP,\~70% or more of the total CTB labeled pSNs were Hoxc8^+^ ([Figure 4f--f,k](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1a--e](#fig4s1){ref-type="fig"}). The biceps brachii is proximally located in relation to the limb, and innervated by Hox5^+^ MNs, while the latter three flexors inhabit the distal forelimb and are supplied by Hoxc8^+^ median and ulnar MNs ([@bib16]). The PM is also considered a proximal forelimb muscle, though it is one of the largest arm flexion-controlling muscles responsible for a wide range of arm movements. Of the injected extensor muscles, including the proximally located triceps (Tri) and distally positioned extensor carpi radialis (ECR) and extensor digitorum (ED), a small to negligible percentage (3--6%) of CTB labeled pSNs expressed Hoxc8 ([Figure 4g--k](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1f--I](#fig4s1){ref-type="fig"}). After injection into the spinodeltoideus, 32% of labeled neurons expressed Hoxc8, possibly reflecting innervation by pSNs with a mixed molecular profile. These results indicate that Hoxc8^+^ pSNs preferentially target muscles involved in distal forelimb flexion.

Sensory neuron survival and differentiation in *Hoxc8^SN∆^* mice {#s2-5}
----------------------------------------------------------------

We next evaluated the function of *Hoxc8* during pSN development by generating homozygous *Hoxc8^LacZ-flox/LacZ-flox^* mice expressing *PLAT::Cre* (referred to henceforth as *Hoxc8^SN∆^* mice). In *Hoxc8^SN∆^* animals, expression of Hoxc8 protein is selectively removed from SNs but maintained by neurons within the spinal cord ([Figure 5---figure supplement 1a](#fig5s1){ref-type="fig"}). Because *Hoxc8* has been shown to be essential for the survival of a subset of caudal cervical LMC neurons after E12.5 ([@bib16]; [@bib62]), this posed the possibility that *Hoxc8* is similarly involved in the selective survival or maintenance of caudal cervical pSNs during embryogenesis. Alternatively, since Hoxc8 expression persists through the 1^st^ postnatal week in sensory neurons this suggests a potential function in later aspects of pSN maturation and connectivity.

We therefore examined the function of *Hoxc8* during midgestation (E14.5-E15.5) and postnatally (P4-P7). To clearly visualize Hoxc8^+^ populations at postnatal stages, we used the inserted *LacZ* reporter which expresses βGal in lieu of *Hoxc8*, enabling us to track the fate of pSNs lacking *Hoxc8*. We compared the number of βGal^+^ cells between *Hoxc8^LacZ/+^* and *Hoxc8^SN∆^* animals in DRG C8, where a subset of Hoxc8^+^ pSNs reside. At P7, the percentage of PV^+^ pSNs that expressed βGal was similar between control and *Hoxc8^SN∆^* animals (42 ± 3% in N = 33 sections from three control mice, versus 45 ± 3% in N = 32 section from 3 *Hoxc8^SN∆^* mice, p=0.43, Student's t test) ([Figure 5a,c](#fig5){ref-type="fig"}). We also compared the fraction of PV^+^ pSNs that expressed Isl1, which was also unchanged (22 ± 1% in N = 68 sections from three control animals, versus 23 ± 1% in N = 74 section from 3 *Hoxc8^SN∆^* mice, p=0.59, Student's t test) ([Figure 5b,c](#fig5){ref-type="fig"}). Moreover, the distribution of sensory neurons expressing Etv1, PV and Isl1 was grossly unchanged in *Hoxc8^SN∆^* animals at E15.5 compared to that of control animals ([Figure 5---figure supplement 1e,f](#fig5s1){ref-type="fig"}). All βGal^+^ cells also lacked Ret expression in *Hoxc8^SN∆^* animals, indicating that their fate had not been switched to that of PV^+^ cutaneous sensory neurons ([Figure 5---figure supplement 1g,h](#fig5s1){ref-type="fig"}). These observations indicate that *Hoxc8* is not required for the survival or maintenance of early pSN molecular features.

![*Hoxc8* is dispensable for pSN survival and differentiation.\
(**a, b**) Example images showing expression of βGal and PV (**a**) or PV and Isl1 (**b**) in controls and *Hoxc8^SN∆^* mice at P7. (**c**) Quantification of fraction of βGal^+^ PV^+^ SNs over total PV^+^ population: 42 ± 3% (mean ± SEM) in N = 33 sections from three mice, versus 45 ± 3% in N = 32 sections from 3 *Hoxc8^SN∆^* mice (p=0.43, Student's t test). Quantification of PV^+^ Isl1^+^ SNs over total Isl1^+^ population: 22 ± 1% in N = 68 sections from three control mice, versus 23 ± 1% for N = 74 sections from 4 *Hoxc8^SN∆^* mice (p=0.59, Student's t test). Data points in graphs show results from individual sections. Lines in graph show mean ± SEM. (**d**) Distal forelimb flexors FCU and PL still receive normal pSN innervation and muscle spindles develop normally in *Hoxc8^SN∆^* mice compared to controls shown with PV and vGlut1 staining. (**e**) Retrograde labeling of βGal^+^ SNs after CTB injection of FCU in control and *Hoxc8^SN∆^* mice. Muscle injection performed at \~P4 and DRG collected at \~P7 P8. (**f**) Quantification of CTB^+^βGal^+^PV^+^/total CTB^+^PV^+^ SNs after FCU retrograde tracing: 65.2 ± 5.1% for N = 4 control mice; 62.3 ± 7.6% for N = 3 *Hoxc8^SN∆^* mice, p=0.75, Student's t test. (**g**) No difference in PV fiber density in the ventral spinal cord between control and *Hoxc8^SN∆^* mice. PV fiber stain with heat map below. (**h**) Quantification of the average PV pixel intensity at DRG C8 level. PV fiber density calculated only in ROI created in ventral spinal cord region. Lines indicate mean ± SEM. Average intensity for control: 82.1 ± 2.4, N = 3 mice. Average intensity for *Hoxc8^SN∆^*: 81.1 ± 1.3, N = 3 mice (p=0.74, Student's t test). See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.\
Figure 5---source data 1.Quantification of sensory markers in control and Hoxc8 mutants.](elife-56374-fig5){#fig5}

To determine if *Hoxc8* is necessary for the ability of cervical pSNs to innervate their normal forelimb muscle targets, we examined the formation of muscle spindles in the palmaris longus (PL) and flexor carpi ulnaris (FCU), two distal forelimb flexor muscles that normally receive input from Hoxc8^+^ pSNs. We found no discernible difference in the pattern of PV or vGlut1, which accumulate on the peripheral terminals of pSNs, indicating that PL and FCU muscle connectivity is unaltered in the absence of *Hoxc8* ([Figure 5d](#fig5){ref-type="fig"}). We also tested whether the FCU receives innervation from appropriate pSN subtypes in the absence of *Hoxc8*. We injected CTB into the FCU of *Hoxc8^SN∆^* mice at P4 and collected spinal cords with attached DRG at P7. We found that the fraction of pSNs that were βGal^+^ CTB^+^ was similar between controls and *Hoxc8^SN∆^* mice (65.2 ± 5.1% for N = 4 controls; 62.3 ± 7.6% for N = 3 *Hoxc8^SN∆^* mice, p=0.75, Student's t test) ([Figure 5e,f](#fig5){ref-type="fig"}). Loss of *Hoxc8* therefore does not preclude the ability of cervical pSNs to reach their normal muscle targets, demonstrating that *Hoxc8* is not essential for pSN peripheral projection and target specificity.

Genetic ablation of early pSN fate determinants, including *Runx3* or *Etv1*, leads to marked reduction in the extension of pSN central afferents into the ventral spinal cord ([@bib2]; [@bib33]). Since deletion of *Hoxc8* does not affect pSN survival or peripheral innervation, we next asked whether *Hoxc8* is required for the ventral extension of pSNs towards MNs. Hoxc8^+^ pSN projections originating from DRG C8 terminate within the ventral spinal cord predominantly at this same segmental level ([@bib5]). Thus, a noticeable loss of projections to the ventral spinal cord would be evident at this segmental position. We used PV labeling to measure the density of pSN collateral projections terminating in the ventrolateral area of the spinal cord. We observed no difference in the mean pixel intensity of PV fibers innervating the region occupied by forelimb MNs between *Hoxc8^SN∆^* mice and controls (82.1 ± 2.4 for N = 3 controls; 81.1 ± 1.3 for N = 3 *Hoxc8^SN∆^* mice, p=0.74, Student's t test) ([Figure 5g,h](#fig5){ref-type="fig"}). Collectively, these results indicate that *Hoxc8* is dispensable for pSN survival, peripheral muscle target selection, and ability of pSNs to extend central axons ventrally.

Altered topography of pSN central connections in *Hoxc8^SN∆^* mice {#s2-6}
------------------------------------------------------------------

We next considered the possibility that deletion of *Hoxc8* disrupts the pattern of central connectivity between muscle-specific pSNs and MNs. To examine pSN synaptic specificity, we employed a modified rabies labeling strategy which directs monosynaptically-restricted anterograde transfer of virus from pSNs to neurons within the spinal cord ([@bib72]). We bred *Hoxc8^SN∆^* mice with a Cre-dependent line (*Gt(ROSA)26Sor^CAG-loxp-STOP-loxp-rabies-G-IRES-TVA^* mice, henceforth referred to as *RGT*) expressing two rabies helper proteins: TVA, an avian-specific receptor protein, which permits infection to rabies virus pseudotyped with EnvA, and a rabies glycoprotein, which allows transsynaptic transfer of the virus, both produced in sensory neurons following recombination using the *PLAT::Cre* line ([Figure 6a](#fig6){ref-type="fig"}). The injected RV∆G-mCherry-EnvA (RabV) virus lacks its own glycoprotein rendering it incapable of spreading in the absence of the supplanted source. Sensory-restricted Cre expression confines the spread of mCherry-expressing rabies from the injected muscle to the connected pSNs, and subsequently their monosynaptically-coupled postsynaptic partners, while preventing infection of MNs directly from the muscle. An advantage of utilizing this method is that the RabV labels the entire soma of infected neurons making it relatively easy to identify coupled MNs.

![Altered central targeting of distal flexor muscle pSNs in *Hoxc8^SN∆^* mice.\
(**a**) Cre-dependent excision of *Hoxc8* coding sequence and expression of *LacZ* reporter driven by *PLAT* promoter. Removal of the stop cassette permits expression of 2 rabies helper proteins, TVA and glycoprotein G, after Cre-recombination thus directing rabies infection in a cell type specific manner (left). Modified rabies virus labeling experimental design: Env/TVA system permits primary infection of SNs; SNs also express glycoprotein G which enables monosynaptic transfer of injected modified rabies virus (RV∆G-mCherry-EnvA) anterogradely to spinal cord MNs by secondary infection (middle). Representative spinal cord cross-section of RV∆G-mCherry-EnvA monosynaptic labeling in MNs via pSN transfer after injection into FCU muscle of *PLAT::Cre; Hoxc8^LacZ-flox/+^* mice (right). (**b and c**) Dot plot showing RV∆G-mCherry-EnvA labeled MNs position of a representative spinal cord hemi-section in the caudal cervical region. Distances from the central canal are shown on x and y coordinate axes (in micrometers). Contour plots to the right depicting labeled MN density in relation to position in spinal cord. Area of greatest labeling density in yellow. Overlay of labeled MN dot plots for both control and *Hoxc8^SN∆^* mice. Total number of labeled MNs in which the FCU is injected in control mice; N = 3 mice, 79 cells. Total number of labeled MNs in *Hoxc8^SN∆^* mice; N = 3 mice, 66 cells (**b**). Total number of labeled MNs in which the PL is injected in control mice; N = 3 mice, 71 cells. Total number of labeled MNs in *Hoxc8^SN∆^* mice; N = 3 mice, 62 cells. See also [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.](elife-56374-fig6){#fig6}

We tested the specificity of this tracing assay by injecting distal flexor muscles with RabV in both Cre^+^ and Cre^-^ *RGT* mice ([Figure 6---figure supplement 1a--d](#fig6s1){ref-type="fig"}). In *PLAT::Cre*^+^ *RGT* mice, RabV injected into flexor muscles labeled the connected pSNs as well as monosynaptically coupled MNs and interneurons, on the ipsilateral side in relation to the injection, via the sensory neuron terminals. By contrast, no RabV labeled sensory or spinal neurons were observed in control experiments where we injected modified rabies virus in *RGT* mice lacking Cre ([Figure 6---figure supplement 1a--d](#fig6s1){ref-type="fig"}). These results indicate that the rabies labeling of MNs is Cre-dependent and mediated through transsynaptic spread via sensory central terminals.

We used this labeling strategy to map the overall distribution of postsynaptic targets of pSNs targeting a specific limb muscle in both control and *Hoxc8^SN∆^ RGT* mice. We injected either the flexor carpi ulnaris (FCU) or the palmaris longus (PL) muscles with RabV, and mapped the location of transynaptically-labeled MNs, marked by Choline Acetyltransferase (ChAT). We then generated scatter plot and contour maps of the distribution of labeled RabV^+^ ChAT^+^ neurons (N = 3 animals). In control mice, injections into the FCU or PL labeled discrete clusters of RabV^+^/ChAT^+^ neurons located in a dorsal region of the caudal LMC ([Figure 6b,c](#fig6){ref-type="fig"}), consistent with the location of the MN pools targeting these muscles ([@bib4]). By contrast, in *Hoxc8^SN∆^* mice rabies tracing from the FCU and PL labeled MNs that extended more ventrally and laterally within the LMC which of note, is typically the domain occupied by forelimb extensor MNs ([Figure 6b,c](#fig6){ref-type="fig"}). These qualitative observations suggest that *Hoxc8* regulates the pattern of pSN connectivity within the ventral spinal cord, presenting the possibility that flexor pSNs lacking *Hoxc8* may target inappropriate postsynaptic MN subtypes.

Ectopic synapses between flexor pSNs and extensor MNs in *Hoxc8^SN∆^* mice {#s2-7}
--------------------------------------------------------------------------

Because Hoxc8 expression is restricted to pSNs innervating distal forelimb flexor muscles, we next asked whether loss of *Hoxc8* leads to inappropriate synapses onto distal forelimb extensor MNs. To examine this, we injected distal flexor muscles with RabV, while concurrently retrogradely labeling MNs through injection of CTB into distal extensor muscles ([Figure 7a](#fig7){ref-type="fig"}). If removal of *Hoxc8* leads to an inappropriate coupling between flexor pSNs and extensor MNs, we would expect to observe colocalization of RabV^+^ with CTB-labeled extensor MNs. Two distal extensor muscles were injected to maximize the possibility of finding ectopically connected MNs, and were also chosen based on their intrasegmental overlap with motor pools of injected flexors. To ensure no cross contamination of injected tracers, only superficial extensor muscles separated by at least three muscles from the injected flexors were chosen.

![Flexor pSNs form ectopic synapses on extensor MNs in *Hoxc8^SN∆^* mice.\
(**a**) Schematic illustrating muscle injection of RV∆G-mCherry-EnvA (RabV). Selective infection of SNs and anterograde transsynaptic transport leads to secondary infection of MNs in the ventral spinal cord but not direct infection of MNs. CTB injected into a muscle labels directly connected MNs. In a normal condition, pSNs avoid synapsing onto antagonist MNs. In a mismatch condition, pSNs form ectopic contacts onto antagonist muscle MNs yielding colocalization of RabV (red) and CTB (green). Individual distal forelimb flexor muscles were injected with RabV and distal forelimb extensors were injected with CTB. Injections were performed at \~P6 P7 and spinal cords were collected at \~P12-13. (**b**) Colocalization of RabV, CTB, and ChAT signifying ectopic contacts in *Hoxc8^SN∆^* mice where RabV was injected into the FCU and CTB was injected into the ECR and ED. (**c**) Quantification of the average percentage of RabV^+^CTB^+^ChAT^+^ cells over total RabV^+^ChAT^+^ cells where RabV was injected into the FCU. Lines indicate mean ± SEM. Average from control mice: N = 5 mice; 0 ± 0. Average from *Hoxc8^SN∆^*: N = 4 mice; 0.26 ± 0.04. (p\<0.0001, Student's t test). (**d**) Colocalization of RabV, CTB, and ChAT signifying ectopic contacts in *Hoxc8^SN∆^* mice where RabV was injected into the PL and CTB was injected into the ECR and ED. (**e**) Quantification of the average percentage of RabV^+^CTB^+^ChAT^+^ cells over total RabV^+^ChAT^+^ cells where RabV was injected into the PL. Lines indicate mean ± SEM. Average from control mice: N = 4 mice; 0.008 ± 0.008. Average from *Hoxc8^SN∆^*: N = 3 mice; 0.37 ± 0.13. (p=0.02, Student's t test). For both *Hoxc8^SN∆^* mice and controls in which the FCU was injected, a total of \~150 RabV MNs were counted while 120 RabV MNs were counted for control mice injected in the PL and 101 RabV MNs for *Hoxc8^SN∆^* mice. See also [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}.\
Figure 7---source data 1.Quantification of rabies labeled neurons in control and Hoxc8 mutants.](elife-56374-fig7){#fig7}

We injected a distal forelimb flexor muscle, FCU or PL, with RabV, and retrogradely labeled both distal forelimb extensor carpi radialis and extensor digitorum MNs with CTB. In control *PLAT::Cre*^+^ *RGT* mice, the set of mCherry-labeled flexor MNs, labeled through transsynaptic viral spread via flexor pSNs, were distinct from retrogradely labeled CTB extensor MNs (control: N = 9 mice; FCU: N = 5, PL: N = 4) ([Figure 7b,d](#fig7){ref-type="fig"}). This result is consistent with electrophysiological and anatomical studies showing that the flexor pSNs do not synapse with extensor MN pools ([@bib25]; [@bib72]).

By contrast, in *RGT Hoxc8^SN∆^* mice we observed ectopic connections originating from distal flexor pSNs onto distal extensor MNs (*Hoxc8^SN∆^*: N = 7 mice; FCU: N = 4, PL: N = 3) ([Figure 7b,d](#fig7){ref-type="fig"}). We quantified the fraction of MNs with coincident detection of RabV/CTB/ChAT over the total number of RabV labeled MNs in each injected animal. We found that in *Hoxc8^SN∆^* mice, in which the FCU is injected with rabies, 29 ± 5%, of the total RabV/ChAT labeled MNs colabeled with CTB (N = 4 mice), compared to 0 ± 0% in control animals (N = 5 mice, p\<0.0001, Student's t-test) ([Figure 7c](#fig7){ref-type="fig"}). Similarly, in *Hoxc8^SN∆^* mice in which the PL was injected with rabies, 37 ± 12% of the total RabV/ChAT labeled MNs were CTB labeled (N = 3 mice), compared to that of 0.8 ± 0.8% in control animals (N = 4 mice, p=0.02, Student's t-test) ([Figure 7e](#fig7){ref-type="fig"}). The percentages likely underrepresent the entire cohort of ectopically connected MN populations, since not all of the pSNs and thus MNs were infected by the rabies virus. Additionally, flexor pSNs ectopically contacted extensor MNs located within the same segments occupied by the flexor MNs, suggesting that flexor pSN projections mistarget within their normal rostrocaudal domains.

To confirm that ectopic synapses were formed by distal flexor pSNs onto distal extensor MNs, we employed a more conventional labeling strategy using CTB and the fluorescent tracer Rhodamine-dextran (Rh-Dex). After intramuscular injection, Rh-Dex is taken up by MNs, as well as pSN afferents, but is not transported transganglionically, thus restricting central tracing to MN soma. CTB, however, transfers into the central sensory axon, and accumulates in vGluT1^+^ sensory boutons at the soma of synaptically-coupled MNs. Thus, after muscle injection we can compare pSN CTB labeling of vGlut1 synapses on Rh-Dex labeled MNs. We injected the FCU with CTB and distal extensor muscles with Rh-Dex in *RGT* control and *RGT Hoxc8^SN∆^* mice. Similar to the results of the rabies tracing assay, we observed the presence of ectopic synapses from CTB/vGlut1 labeled distal flexor pSNs onto distal extensor Rh-Dex^+^ MNs ([Figure 7---figure supplement 1a--c](#fig7s1){ref-type="fig"}). Together, these results indicate that *Hoxc8* plays an important role in pSNs during sensory-motor circuit development.

Discussion {#s3}
==========

Animals rely on internal neural representations of muscle position and activity in order to execute coordinated motor behavior ([@bib1]; [@bib48]; [@bib64]). In vertebrates, pSNs establish selective central connections with MNs innervating the same peripheral muscle, while avoiding MNs targeting functionally antagonistic muscles. Whether pSNs are intrinsically programmed to acquire muscle-specific identities that enable them to target appropriate central postsynaptic targets is largely unknown. A major roadblock in resolving the mechanisms of spinal sensory-motor circuit assembly has been a lack of molecular tools to study muscle-specific pSN subtype differentiation. We found that pSNs innervating distal forelimb muscles can be defined by selective expression of Hox transcription factors, and these profiles are initiated independent of limb-derived cues. Additionally, *Hox* genes are critical in generating appropriate patterns of central connections between pSNs and MNs. We suggest that the coordinate activity of *Hox* genes in multiple neuronal classes plays a key role in establishing synaptic specificity within developing limb control circuits.

*Hox* genes and sensory neuron diversification {#s3-1}
----------------------------------------------

Hox transcription factors are well known intrinsic determinants of patterning and cellular identities along the rostrocaudal axis of metazoans ([@bib43]; [@bib54]). Our results indicate that, in addition to their broad roles in determining rostrocaudal positional identities, *Hox* genes have neuronal class-specific functions associated with the development of limb sensory-motor circuits. Our findings reveal that a subset of *Hox* genes are selectively expressed by pSNs generated at specific segmental levels, and these patterns parallel the rostrocaudal profiles of *Hox* genes in the CNS. We found that the *Hoxc8* gene is preferentially expressed by pSNs targeting distal forelimb flexor muscles, important for wrist and digit movement, reflecting the Hoxc8 expression domain in MNs. While our studies focused on a single *Hox* gene, it is likely that other forelimb-specific pSN subtypes can be similarly delineated by specific combinations of *Hox4-Hox8* genes.

It is notable that pSNs express members of the *Hoxa* and *Hoxc* gene clusters, while *Hoxb* genes appear to be expressed by broader populations of sensory neurons, most of which are likely cutaneous. These patterns are reminiscent of the differential expression of *Hox* genes within the spinal cord, where *Hoxb* genes are typically expressed in dorsal populations, containing cutaneous sensory relay interneurons, while *Hoxa* and *Hoxc* genes are expressed by motor-related interneurons and MNs ([@bib20]; [@bib28]; [@bib60]). Dorsoventral differences in *Hox* patterning appear to emerge developmentally, as *Hox* transcripts are initially expressed uniformly in neural progenitors along the dorsoventral axis ([@bib42]). While the mechanisms that govern the later bias of *Hoxa/c* and *Hoxb* expression in muscle and cutaneous sensory systems are unclear, they could relate to the timing of differentiation. In the spinal cord, ventral motor-related postmitotic neurons are born prior to dorsal types, and DRG neurons appear to exhibit a similar proprioceptive to cutaneous temporal progression ([@bib26]; [@bib40]).

The dorsoventral restriction of genes within *Hox* clusters could provide a mechanism to diversify subtype identity across multiple sensory modalities. As cutaneous neurons are known to terminate in the dorsal spinal cord, the coordinate activities of *Hoxb* genes could similarly function in the development of cutaneous sensory-relay circuits. Consistent with this idea *Hoxb8* has been shown to be essential for normal development and organization of dorsal spinal interneurons, and loss of *Hoxb8* leads to excess grooming and reduced thermal and nociceptive response ([@bib30]).

Extrinsic and intrinsic control of sensory-motor circuit development {#s3-2}
--------------------------------------------------------------------

Studies of sensory neuron development provide compelling evidence that a major determinant of subtype diversity and connectivity are instructive cues provided by peripheral limb muscle and mesenchyme. Expression of *Ntf3* within the developing limb regulates expression of *Etv1* and *Runx3* in pSNs, and differences in the levels of NT3 signaling contribute to muscle specific identities ([@bib22]; [@bib66]). The limb mesenchyme has also been implicated as a source of extrinsic cues which differentiate hindlimb extensor and flexor pSN subtypes ([@bib57]; [@bib67]). A confounding aspect in the study of limb-derived signaling in pSN development is that peripheral *Ntf3* signaling, as well as the intrinsic determinants *Etv1* and *Runx3*, are also required for sensory neuron survival, often precluding genetic analysis of later aspects of sensory-motor circuit development.

We found that *Hoxc8* is dispensable for pSN survival, and loss of *Hoxc8* does not prohibit the ability of pSNs to target their appropriate forelimb muscle targets. Moreover, expression of *Hox* genes in both forelimb-innervating pSNs and MNs is maintained in the absence of limb mesenchyme and muscle. While these results indicate a limb-independent mechanism of early neuronal differentiation, target-derived cues are likely required to establish the full molecular profiles of pSNs and functional characteristics. In spinal MNs, a major function of *Hoxc8* is to regulate expression of *Ret* and *Gfrα* genes, rendering a subset of MNs sensitive to activities of peripheral Gdnf to induce *Pea3* expression within motor pools ([@bib16]). Thus, in MNs Hox proteins regulate expression of cell surface receptors that retrogradely influence subtype specification. *Hox* genes may similarly act in pSNs to modify or constrain the responses to peripheral cues as sensory axons navigate through the developing limb bud.

Expression of *Hoxc8* in pSNs is largely confined to distal forelimb flexor subtypes, while distal forelimb extensor pSNs lack *Hoxc8* pSN innervation. Interestingly, a recent study showed that *Runx3* is essential for the development of forelimb extensor pSNs, and suggests that this pattern is regulated by limb-derived cues ([@bib66]). The differential expression of *Hoxc8* and *Runx3* in distal flexors and extensors could reflect refinement in the pattern of these factors by limb-derived cues. For example, Hoxc8 may antagonize Runx3 function within flexor pSN subtypes. Alternatively, limb-derived cues may maintain Runx3 in extensor pSNs and restrict *Hoxc8* expression to forelimb flexor pSNs.

*Hox* genes and synaptic specificity in sensory-motor circuits {#s3-3}
--------------------------------------------------------------

We found that *Hoxc8* is required in distal forelimb flexor pSNs to establish appropriate connections with their MN counterparts. How do *Hox* genes contribute to the specificity of central connections between pSNs and MNs? In spinal MNs, *Hox* genes and their downstream targets including *Pea3* and *Sema3e* have been shown to be essential for the specificity of their central connections with pSNs ([@bib5]; [@bib53]; [@bib65]), in part, by regulating MN topographical organization and dendritic architecture. In mice lacking the Hox accessory factor *Foxp1* the normal positioning of forelimb-innervating MNs is disrupted, leading to a sensory-motor mismatch ([@bib59]). The specificity of pSN-MN connections has been recently shown to correlate with the relative approach angles between pSN axons and MN dendrites ([@bib7]), and loss of this alignment may account for the sensory-motor mismatch observed in both *Foxp1* and pSN *Hoxc8* mutants. Further studies will be necessary to definitively assess whether the coordinate regulation of MN and pSN connectivity by the same *Hox* gene contributes to sensory-motor specificity. Consistent with this model, in preliminary studies we found that after selective deletion of *Hoxc8* from MNs, MN pools are disorganized and distal forelimb flexor pSNs target extensor MNs ([Figure 5---figure supplement 1c,d](#fig5s1){ref-type="fig"}, [Figure 7---figure supplement 1d,e](#fig7s1){ref-type="fig"}). Although a Hox-specific molecular matching model for pSN-to-MN connectivity is provocative, *Hoxc8* could be required in pSNs, independent of *Hoxc8* in MN, for the segregation of axonal subtypes within the sensory nerve, or for their axon guidance within the spinal cord.

Centrally, pSNs establish connections with a variety of postsynaptic targets, including local spinal and projection interneurons that relay proprioceptive information to the brain ([@bib10]; [@bib11]; [@bib36]; [@bib63]; [@bib71]). The same *Hox* genes expressed by pSNs and MNs are also expressed by multiple classes of spinal interneurons, suggesting a broader role in shaping synaptic specificity within the spinal cord. Consistent with this idea, both long ascending spinocerebellar and local-circuit spinal interneurons have been shown to require *Hox* function to acquire limb-specific molecular identities ([@bib6]; [@bib60]). Results from this work indicate that in addition to contributing to sensory neuron diversity, *Hox* genes are also required in pSNs to shape synaptic specificity in developing sensory-motor circuits. These observations are consistent with studies indicating that coordinate *Hox* activities are required in multiple neuronal and non-neuronal lineages during circuit assembly ([@bib8]; [@bib13]; [@bib73]). Our findings suggest the same *Hox* gene could act in multiple neuronal classes during development, implying a coherent molecular strategy for wiring the circuits essential for limb control.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                      Designation                                                Source or reference                                              Identifiers                                                                      Additional\
  (species) or resource                                                                                                                                                                                                                           information
  ---------------------------------- ---------------------------------------------------------- ---------------------------------------------------------------- -------------------------------------------------------------------------------- --------------------------
  Genetic reagent (*M. musculus*)    *Hoxc8 flox*                                               PMID:[19621436](https://www.ncbi.nlm.nih.gov/pubmed/19621436)    MGI: 4365797                                                                     

  Genetic reagent (*M. musculus*)    *PLAT::Cre*                                                PMID:[12812797](https://www.ncbi.nlm.nih.gov/pubmed/12812797)    MGI: 3052515                                                                     

  Genetic reagent (*M. musculus*)    *Olig2::Cre*                                               PMID:[18046410](https://www.ncbi.nlm.nih.gov/pubmed/18046410)    MGI: 3774124                                                                     

  Genetic reagent (*M. musculus*)    *Gt(ROSA)26Sor::CAG-loxp-STOP-loxp-rabies-G-IRES-TVA*      PMID:[23352170](https://www.ncbi.nlm.nih.gov/pubmed/23352170)    MGI: J:206510                                                                    

  Biological sample (rabies virus)   *EnvA-RabV-mCherry* (pseudotyped G-deleted rabies virus)   PMID:[21867879](https://www.ncbi.nlm.nih.gov/pubmed/21867879)\                                                                                    \~10^8^ IU/mL
                                                                                                PMID:[17329205](https://www.ncbi.nlm.nih.gov/pubmed/17329205)\                                                                                    
                                                                                                PMID:[26844832](https://www.ncbi.nlm.nih.gov/pubmed/26844832)                                                                                     

  Biological sample (chicken eggs)   SPF Eggs                                                   Charles River                                                    10100332                                                                         

  Antibody                           anti-Hoxc4 (Rabbit polyclonal)                             PMID:[16269338](https://www.ncbi.nlm.nih.gov/pubmed/16269338)                                                                                     (1:16000)

  Antibody                           anti-Hoxa5 (Rabbit polyclonal)                             PMID:[16269338](https://www.ncbi.nlm.nih.gov/pubmed/16269338)                                                                                     (1:16000)

  Antibody                           anti-Hoxc6 (Guinea pig polyclonal)                         PMID:[11754833](https://www.ncbi.nlm.nih.gov/pubmed/11754833)    RRID:[AB_2665443](https://scicrunch.org/resolver/AB_2665443)                     (1:16000)

  Antibody                           anti-Hoxc6 (Rabbit polyclonal)                             Aviva Systems Biology                                            Cat\# ARP38484; RRID:[AB_10866814](https://scicrunch.org/resolver/AB_10866814)   (1:32000)

  Antibody                           anti-Hoxa7 (Guinea pig polyclonal)                         PMID:[16269338](https://www.ncbi.nlm.nih.gov/pubmed/16269338)                                                                                     (1:32000)

  Antibody                           anti-Hoxc8 (Mouse monoclonal)                              Covance                                                          RRID:[AB_2028778](https://scicrunch.org/resolver/AB_2028778)                     (1:4000)

  Antibody                           anti-Hoxb4 (Rat monoclonal)                                Developmental Studies Hybridoma Bank                             Cat\# I12; RRID:[AB_2119288](https://scicrunch.org/resolver/AB_2119288)          (1:100)

  Antibody                           anti-Hoxb5 (Rabbit polyclonal)                             PMID:[23103965](https://www.ncbi.nlm.nih.gov/pubmed/23103965)                                                                                     (1:32000)

  Antibody                           anti-Foxp1 (Rabbit polyclonal)                             PMID:[18662545](https://www.ncbi.nlm.nih.gov/pubmed/18662545)    RRID:[AB_2631297](https://scicrunch.org/resolver/AB_2631297)                     (1:32000)

  Antibody                           anti-Isl1/2 (Mouse monoclonal)                             Developmental Studies Hybridoma Bank                             Cat\# 39.4D5, RRID:[AB_2314683](https://scicrunch.org/resolver/AB_2314683)       (1:50)

  Antibody                           anti-Isl1/2 (Rabbit polyclonal)                            Jessell lab                                                                                                                                       (1:5000)

  Antibody                           anti-Meis2 (Rabbit polyclonal)                             PMID:[16269338](https://www.ncbi.nlm.nih.gov/pubmed/16269338)                                                                                     (1:16000)

  Antibody                           anti-Pbx3 (Rabbit polyclonal)                              PMID:[16269338](https://www.ncbi.nlm.nih.gov/pubmed/16269338)                                                                                     (1:16000)

  Antibody                           anti-Pea3 (Rabbit polyclonal)                              PMID:[9814709](https://www.ncbi.nlm.nih.gov/pubmed/9814709)      RRID:[AB_2631446](https://scicrunch.org/resolver/AB_2631446)                     (1:32000)

  Antibody                           anti-βGal (Goat polyclonal)                                Abcam                                                            Cat\# 9361; RRID:[AB_307210](https://scicrunch.org/resolver/AB_307210)           (1:1000)

  Antibody                           anti-βGal (Goat polyclonal)                                Santa Cruz                                                       Cat\# sc-19119; RRID:[AB_2111604](https://scicrunch.org/resolver/AB_2111604)     (1:2000)

  Antibody                           anti-Ret (Goat polyclonal)                                 Santa Cruz                                                       Cat\# sc-1290; RRID:[AB_631316](https://scicrunch.org/resolver/AB_631316)        (1:100)

  Antibody                           anti-CTB (Goat polyclonal)                                 List Biological Laboratories                                     Cat\# 703; RRID:[AB_10013220](https://scicrunch.org/resolver/AB_10013220)        (1:4000)

  Antibody                           anti-vGlut1 (Guinea pig polyclonal)                        Millipore                                                        Cat\# AB5905; RRID:[AB_2238022](https://scicrunch.org/resolver/AB_2238022)       (1:1000)

  Antibody                           anti-PV (Rabbit polyclonal)                                Swant                                                            Cat\# PV27; RRID:[AB_2631173](https://scicrunch.org/resolver/AB_2631173)         (1:1000)

  Antibody                           anti-Runx3 (Rabbit polyclonal)                             Abcam                                                            Cat\# ab68938; RRID:[AB_1141661](https://scicrunch.org/resolver/AB_1141661)      (1:16000)

  Antibody                           anti-TRITC (Rabbit polyclonal)                             Thermofisher                                                     Cat\# A6397; RRID:[AB_2536196](https://scicrunch.org/resolver/AB_2536196)        (1:1000)

  Antibody                           anti-Ret (Rabbit polyclonal)                               Cell Signaling                                                   Cat\# 3223; RRID:[AB_2238465](https://scicrunch.org/resolver/AB_2238465)         (1:100)

  Antibody                           anti-ChAT (Rabbit polyclonal)                              Jessell Lab                                                                                                                                       (1:16000)

  Antibody                           anti-Etv1 (Rabbit polyclonal)                              Jessell Lab                                                                                                                                       (1:8000)

  Antibody                           anti-βGal (Chick polyclonal)                               Jessell Lab                                                                                                                                       (1:5000)

  Antibody                           anti-cRunx3 (Guinea pig polyclonal)                        Jessell Lab                                                                                                                                       (1:5000)

  Antibody                           Alexa 488-, Cy3-, Alexa 647- secondaries\                  Jackson ImmunoResearch                                                                                                                            (1:1000)
                                     (Donkey polyclonal)                                                                                                                                                                                          

  Peptide, recombinant protein       1% Cholera Toxin B subunit                                 Sigma-Aldrich                                                    Cat\# C9903                                                                      

  Chemical compound, drug            Dextran, Tetramethyl- rhodamine                            ThermoFisher                                                     Cat\# D3308                                                                      

  Software, algorithm                Fiji                                                       PMID:[22743772](https://www.ncbi.nlm.nih.gov/pubmed/22743772)    RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)                     <http://imagej.net/Fiji>

  Software, algorithm                Imaris                                                     Bitplane/Oxford Instruments                                      v8.1.2\                                                                          
                                                                                                                                                                 RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370)                     

  Software, algorithm                Matlab                                                     Mathworks                                                        R2019b\                                                                          
                                                                                                                                                                 RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)                     

  Software, algorithm                GraphPad Prism                                             GraphPad Software                                                8.0.2 (263)                                                                      
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mouse genetics {#s4-1}
--------------

*PLAT::Cre* ([@bib55]), *Hoxc8 flox* ([@bib12]), *Olig2::Cre* ([@bib23]), and *RGT* ([@bib61]) mouse lines have been previously described. Cre-floxed systems for targeted gene deletion were used to obtain genotypes of interest. Breeding combinations of *PLAT::Cre* with *Hoxc8 flox* were performed to generate conditional heterozygous mice (*Hoxc8^LacZ-flox/+^*) as well as homozygous mutant mice (*Hoxc8^SN∆^*). *Hoxc8^LacZ-flox/+^* and Cre negative *Hoxc8 flox* mice were used as controls. No gross phenotypic differences between *Hoxc8^LacZ-flox/+^, Hoxc8 flox* and wild-type mice were observed. Breeding combinations of homozygous *RGT* mice were mated with homozygous *Hoxc8 flox* mice to obtain *Hoxc8 flox-RGT* mice. *Hoxc8^SN∆^* and *Hoxc8^LacZ-flox/+^* were then bred with *Hoxc8 flox-RGT* to generate mice heterozygous for both *Hoxc8 flox* and *RGT, Hoxc8^SN∆^-RGT ^flox/+^* as well as *Hoxc8^LacZ-flox/+^-RGT ^flox/+^. Hoxc8 flox* mice were crossed with *Olig2::Cre* mice to generate MN-specific mutants (*Hoxc8^MNΔ^* mice). Animal work was approved by the Institutional Animal Care and Use Committee of the NYU School of Medicine in accordance with NIH guidelines.

Immunohistochemistry {#s4-2}
--------------------

Mouse embryos were harvested between E11.5 to E18, fixed in 4% paraformaldehyde (PFA) for 1.5--2 hr, cryoprotected in 30% sucrose/PBS overnight and cryosectioned at 10 um or 16 um thickness. Postnatal day P4-P10 mice were perfused with PBS and 4% PFA and post-fixed for 2 hr at 4C prior to cryoprotection and cryosectioning. Primary antibodies against Hox proteins, Foxp1, Isl1/2, Meis2 and Pea3 have been previously described ([@bib20]; [@bib35]). Additional antibodies used: Hoxc8-Alexa 488 (mouse, 1:2000, Covance), Hoxc6 (rabbit, 1:32000, Aviva Systems Biology), βGal (goat, 1:2,000, Santa Cruz), Ret (goat, 1:100, Santa Cruz), CTB (goat, 1:4,000, List Biological Laboratories), vGluT1 (guinea pig, 1:1,000, Millipore), PV (rabbit, 1:1000, Swant), Runx3 (rabbit, 1:16,000, Abcam), TRITC (rabbit, 1:1,000, ThermoFisher), Ret (rabbit, 1:100, Cell Signaling), ChAT (rabbit, 1:16,000, Jessell lab), Etv1 (rabbit, 1:8000, Jessell lab), βGal (chicken, 1:5,000, Jessell lab), βGal (chicken, 1:1,000, Abcam), Islet1/2 (mouse, 1:50, Developmental Studies), Pbx3 (guinea pig, 1:16,000, Dasen lab), cRunx (guinea pig, 1:5,000, Jessell lab). Detailed protocols for histology are available on the J.S.D. lab website (<http://www.med.nyu.edu/dasenlab/>).

Chick limb ablations {#s4-3}
--------------------

Unilateral limb ablations were performed between stages 16--18 ([@bib15]) and embryos incubated to develop to stages 26--28. Embryos were sacrificed and further processed once full limb ablation was confirmed. Spinal cords with attached DRG were dissected and immersed in 4%PFA for 1--2 hr at 4C followed by cryprotection in 30% sucrose overnight. Tissue was cryosectioned at 16 um.

Muscle extraction {#s4-4}
-----------------

Mice were sacrificed at P12 by transcardial perfusion and whole muscle dissections were performed with the animal preparation submerged in ice cold 1X PBS solution. Following removal, each muscle was pinned down in a sylgard plate and immersed in 4%PFA for 2 hr at 4C followed by cryoprotection in 30% sucrose solution overnight. Muscles were embedded in mounting media and cryosectioned at 16 um thickness.

Virus production {#s4-5}
----------------

Local stocks of virus were used to amplify, purify, and concentrate rabies virus (RV∆G-mCherry-EnvA) according to established protocols ([@bib51]; [@bib68]). RV∆G-mcherry virus was produced and amplified in B7GG cells and subsequently pseudotyped with EnvA in BHK-EnvA cells to produce RV∆G-mCherry-EnvA with minor modifications to protocol. After BHK-EnvA cells were infected,\~7 hr later, cells were washed three times in PBS and fresh medium was added, and this was repeated the following day. After a subsequent 48 hr incubation, medium was harvested, filter purified, and viral particles were concentrated by ultracentrifugation. Concentrated virus was then resuspended in PBS and viral titer was assessed by serial dilution of the virus on HEK293t cells to achieve a viral titer of \~1×10^8^ IU/mL.

Tracing experiments {#s4-6}
-------------------

### Sensory neuron labeling {#s4-6-1}

1% CTB (Sigma-Aldrich) solutions were injected with a glass capillary into a forelimb muscle of anesthetized mice at P4-P5 and examined after 3 days. Pups were perfused with PBS and 4% PFA. Spinal cords with attached DRG were isolated and post-fixed for 2--3 hr at 4C. Tissue was cryosectioned at 16 um following cryoprotection.

### Sensory and motor neuron labeling {#s4-6-2}

For anterograde labeling of sensory and motor neurons,\~0.8 uL of RV∆G-mCherry-EnvA virus was injected with a glass capillary into either the FCU or PL of anesthetized mice at P5-P6 which were then perfused with PBS and 4% PFA 5 days later. Spinal cords were isolated, processed, and cryosectioned at 16 um or 30 um. Muscle injection specificity was verified post-mortem by the exclusive presence of fluorescent labeling in muscle of interest.

### Double labeling {#s4-6-3}

To anterogradely label sensory neurons and monosynaptically connected motor neurons, RV∆G-mCherry-EnvA virus was injected into either the FCU or PL of mice at \~P5, as described above, for analysis of ectopically labeled motor neuron soma. Concurrently,\~10--50 nl of 1% CTB solution was injected into the ECR and ED muscles. Animals were perfused with PBS and 4% PFA 5 days later. Spinal cords were isolated, processed, and cryosectioned at 16 um.

To anterogradely label sensory neuron synapses onto motor neurons,\~30--50 nl of 1% CTB solution was injected into either the FCU or PL muscle of \~P5 mice, as described above. Concurrently, TMR-Dextran (Rh-Dex) was injected into the ECR and ED muscles to retrogradely label motor neurons. Animals were perfused with PBS and 4% PFA \~3 days later. Spinal cords were isolated, processed, and cryosectioned at 30 um.

Quantification and statistical analyses {#s4-7}
---------------------------------------

### Neuronal cell counts and muscle spindle analysis {#s4-7-1}

Neuronal cell counts were performed on 10 or 16 um cryosections obtained from caudal cervical DRG. Images were acquired using an LSM 700 Zeiss confocal microscope and cell counts were calculated using the Fiji/ImageJ cell counter feature. For chick limb ablation assays, neuronal cell counts were compared between DRG of the ablated and non-ablated sides of an individual chick embryo. Neuronal cell counts in which forelimb muscles were injected with 1% CTB were performed on 16 um cryosections from caudal cervical DRG and processed/analyzed as described above. Quantifications were done based on comparable labeling efficiency between all injected animals for each muscle type and was required to have a minimum of 10 PV^+^ CTB-labeled sensory neurons. Tissue sections of 16 um thick muscle tissue were imaged to analyze muscle spindle projections. Sensory endings within muscle spindles were identified based on the presence of vGluT1^+^ terminals with characteristic annulospiral morphology. While each unique spindle of an entire muscle was not counted, a series of sections of the whole muscle was profiled to obtain a representative sample of muscle spindles for each muscle. For both cell counts and spindle analysis, serial sections throughout the entire tissue sample were collected into 8 and 5 parallel series of sections respectively and at least one full series of sections was compared between controls and mutants or limb ablated chick embryos. Analyses were performed on N ≥ 3 mice/genotype or per muscle type and N = 3 limb ablated chick embryos.

### Quantification of pSN collateral density (PV fiber density) {#s4-7-2}

Quantitative analysis of pSN fiber density in the ventrolateral region of the spinal cord was performed on collapsed confocal Z-stacks using Fiji/ImageJ analysis software. The total PV+ collateral area (calculated as the mean pixel intensity) was measured within a confined lateral region of the ventral spinal cord at the segmental level of DRG C8 set by the borders of the midline and the ventral and lateral gray matter and white matter boundaries. An ROI was set to cover the ventrolateral region to be quantified and measured 45,832 pixels. The threshold was designated based on PV labeling only in the ventrolateral area and the same threshold value was used across all animals. For each genotype, N = 3 animals were analyzed.

### Quantitative analysis of motor neuron position {#s4-7-3}

Plotting of labeled motor populations was performed on 30 um cryosections. Tiled images were acquired with a Zeiss confocal microscope (LSM 700) at 10X. X-Y coordinates for motor neuron soma measured in um units were determined with respect to the central canal using IMARIS software. Contour plots were generated from the X-Y scatter plots and six isolines were automatically assigned in Matlab.

### Quantitative analysis of ectopic motor neuron soma {#s4-7-4}

RV∆G-mCherry-EnvA/CTB/ChAT labeled motor neurons were analyzed from 16 um serial cryosections of the cervical spinal cord. Coincident labeling of soma was quantified using the cell counter feature in ImageJ. For each genotype/forelimb flexor muscle type, at least N = 3 animals were analyzed. Only animals with comparably efficient labeling were used for analysis. Efficient labeling was designated as a minimum of 20 CTB/ChAT^+^ MNs and 10 RabV/ChAT^+^ MNs. Serial sections throughout the entire tissue sample were collected into 10 parallel series of sections and three full series of sections were compared for each animal.

### Analysis of sensory synaptic contacts with motor neurons {#s4-7-5}

Analysis of vGluT1^+^ sensory bouton contacts with P7--P9 motor neuron soma and ∼100 μm proximal dendritic arbor was performed using 0.4 μm confocal z stacks of 30 μm thick sections using a 63X oil objective lens. Gamma-motor neurons were excluded from analysis. Distance of boutons on dendritic arbor from soma was assessed using the scale bar set by Zen software. Images were analyzed using Fiji/ImageJ.

Statistics {#s4-8}
----------

Samples sizes were determined based on previous experience and the number of animals and definitions of N are indicated in the main text and figure legends. In figures where a single representative image is shown, results are representative of at least two independent experiments, unless otherwise noted. No power analysis was employed, but sample sizes are comparable to those typically used in the field. Data collection and analysis were not blind. Graphs of quantitative data are plotted as means with standard error of mean (SEM) as error bars, using Prism 8 (Graphpad) software. Significance was determined using unpaired (Student's) t-test and was calculated using Prism eight software. Exact p values are indicated in the main text and figure legends.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The paper presents a new model of extrinsic and intrinsic control of sensory-motor circuit development, and how *hox* genes regulate synaptic specificity in sensory-motor circuits. We think that *eLife* readers will be interested in the findings, and we thank the authors for their detailed attention to the reviewer criticisms, most importantly the addition of quantification of the results for the benefit of our readers.

**Decision letter after peer review:**

Thank you for submitting your article \"Intrinsic control of neuronal diversity and synaptic specificity in a proprioceptive circuit\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in *eLife* but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.

Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in *eLife*, either of which would be linked to the original paper.

Summary:

The role of *Hox* genes in sensory-motor circuit assembly is largely unknown. The role for pSN *Hox* codes in synaptic specificity has been poorly explored because 1) *Hox* deletion needs to be conditional to prevent MN defects or lethality, and 2) pSNs innervating different muscles are intermingled inside a dorsal root ganglion (DRG), making it difficult to individually study synaptic targeting of each pSN subtype. This is a careful study addressing intrinsic mechanisms of neuronal specificity and the role of *Hox* transcription factors circuit generation-in this case matching proprioceptive sensory neurons to their targets both in muscle and spinal cord neurons. The authors have overcome these challenges by utilizing a Cre line specific to spinal sensory neurons, and also by introducing a new anterograde labeling technique. This virus-mediated labeling approach is particularly remarkable because this enables selective visualization of entire MNs that a given sensory subtype synapses on, despite their sparse distribution inside a DRG. With this strategy, the authors successfully demonstrated that *Hoxc8* is required for caudal pSNs to form specific monosynaptic connections with their appropriate MN targets. This study demonstrates that *Hoxc8* in subsets of dorsal root ganglia neurons is not required for survival of the neurons, matching to muscles, or extending to the appropriate region within the spinal cord. But *Hoxc8* is required in the sensory neurons for precisely targeting the motor neurons innervating limb flexor muscles, and in its absence, the sensory neuron forms inappropriate synapses on motor neurons for limb extensor muscles. These findings are convincingly shown and carefully reported. Although this is shown for one *Hox* factor, this may have broader impact as a mechanism for sensory-motor matching. Results from this study suggest that the coordinated regulation of the same *Hox* gene in pSN and MNs is essential for the specificity of connections in proprioceptive circuits. This paper suggests a novel molecular code that defines muscle- specific proprioceptive sensory neurons subtypes, shows that proprioceptive sensory neurons subtype identities are intrinsically programmed in early development, and that *Hox* genes are required for proprioceptive sensory neurons central afferents to target the appropriate postsynaptic targets within the spinal cord. In terms of significance the work is appropriate for publication in *ELife*.

Both reviewers had misgivings about the work. For example, in its current form, reviewers point out many places where there is insufficient data to support the conclusions that are being made. Also, where the data is sufficient to make a conclusion, other interpretations that could be equally valid and are not ruled out.

Essential revisions:

1\) While the most challenging experiments in the paper (Figures 4, 6 and 7) are quantified, many of the foundational experiments in the earlier figures are represented by a single image, with no n\'s and consequently no statistical analysis. In some cases, these are key negative findings, such as in the limb bud extirpation experiment in Figure 2 and Figure 2---figure supplement 1 (see below) or the very important finding that conditional knockout of *Hoxc8* in sensory neurons doesn\'t alter pSN identity (Figure 5E -- see below).

2\) The important positive result of the altered localization of pSN synapses on motor neurons after conditional KO of *Hoxc8* in SNs or MNs in Figure 7---figure supplement 2 is presented anecdotally. In some cases where quantitative data has been obtained, such as in Figure 6, it is not determined whether differences are statistically significant. Although the intrinsic *Hox* code model for sensorimotor circuit formation is an appealing one and the experiments are perfectly designed to test it, the lack of quantitation of much of the data presented in the paper make it difficult to assess whether the model is supported.

3\) The first few figures describe the expression of the *Hox* family factors in the dorsal root ganglia. This is important for setting up ideas on how they make function. However, as presented, it is not clear which *Hox* factors were actually assessed (it says Hox4-8-is this all clusters? Were some not looked at?) and what the characteristics are for each? The Materials and methods section doesn\'t help either because it just states the antibodies for the *Hox* factors have been described. This information needs to be more precise. We suggest a table summarizing all the Hox factors tested and a description of the characteristics would be valuable (supplement is fine). These should include the points made in the first few figures like is it expressed in DRG and does it overlap with markers of proprioceptive identity, what is the rostral caudal restriction if any, which *Hox* factors are co-expressed.

4\) Limb bud removal experiments: In arguing for an autonomous *Hox* program in pSNs, this paper contradicts previous reports showing that muscle-derived cues specify pSN identity and connectivity with MNs. The key finding in the current paper supporting an intrinsic mechanism is the chick limb bud extirpation experiments in Figure 2 and Figure 2---figure supplement 1. However, the conclusions need to be better supported. While Figure 2I gives the sense that *Hoxc8* expression is unaffected after limb bud removal, Figure 2---figure supplement 1C reveals that only a small fraction of *Hoxc8*-expressing neurons is in fact pSNs (this is different from mouse). If most of the *Hoxc8*-expressing sensory neurons are cutaneous, it is expected that they would be unaffected by removal of limb bud muscles. Figure 2---figure supplement 1C is thus the more important finding if it shows that the number of *Hoxc8*-expressing pSNs is unaffected after limb bud ablation. However, the number of *Hoxc8^+^Runx3^+^* neurons is small (2-3) in both images. More n\'s and quantification of *Hox^+^Runx3^+^* neurons are needed to support the conclusion that pSN *Hox* expression is unaffected by removal of the limb bud.

5\) Figure 1---figure supplement 1A: schematizes *Hox* expression in DRGs along the rostro-caudal axis but the data only shows where the various *Hox* genes are expressed, not where they are not expressed, so we have to trust that the schematic accurately represents data that is not shown. All the rostro-caudal levels that are included in the schematic should be shown for all four *Hox* genes, as these authors did very beautifully in Catela et al., 2016 Figure 1.

6\) Figure 5E is an important figure showing that pSN identity is unaffected by conditional KO of *Hoxc8*. Rather than being presented as a single figure with three or four co-expressing neurons, this experiment should be done in *Hoxc8* SN∆ mutants as quantitatively as the wildtype data presented in Figure 4.

7\) Based on the finding in Figure 7 showing that *Hoxc8* mutant pSNs inappropriately target extensor-innervating motor neurons, the authors conclude that a *Hox* matching mechanism required for synapse formation between pSNs and their appropriate MN targets has been disrupted. While this is an appealing possibility, other interpretations are equally possible. For instance, *Hoxc8* may be important for the segregation of pSN axon subtypes in the sensory nerve, or for their axon guidance within the spinal cord. A prediction of the *Hox* matching mechanism is that flexor-innervating pSNs will fail to synapse on flexor-innervating MNs in *Hoxc8* MN∆ animals and may inappropriately innervate extensor-innervating MNs. A single example of the latter result is shown (Figure 7---figure supplement 2D, E) -- more examples of this outcome would strengthen the *Hox* matching model.
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Author response

> Essential revisions:
>
> 1\) While the most challenging experiments in the paper (Figures 4, 6 and 7) are quantified, many of the foundational experiments in the earlier figures are represented by a single image, with no n\'s and consequently no statistical analysis. In some cases, these are key negative findings, such as in the limb bud extirpation experiment in Figure 2 and Figure 2---figure supplement 1 (see below) or the very important finding that conditional knockout of Hoxc8 in sensory neurons doesn\'t alter pSN identity (Figure 5E -- see below).

We have addressed each of these issues with additional quantification, further analyses, and provision of specific information on: 1) the number of animals analyzed for each experiment, including those in which a single representative image is shown, 2) clarifying the specific statistical methods used in the paper, and 3) further quantifying the results presented in Figures 2, Figure 2---figure supplement 1, and Figure 5. New quantifications are now plotted in Figures 2F, J, K, L, Figure 5F and Figure 2---figure supplement 1D. See details below.

> 2\) The important positive result of the altered localization of pSN synapses on motor neurons after conditional KO of Hoxc8 in SNs or MNs in Figure 7---figure supplement 2 is presented anecdotally. In some cases where quantitative data has been obtained, such as in Figure 6, it is not determined whether differences are statistically significant. Although the intrinsic Hox code model for sensorimotor circuit formation is an appealing one and the experiments are perfectly designed to test it, the lack of quantitation of much of the data presented in the paper make it difficult to assess whether the model is supported.

In the revision we now provide a more thorough quantification of key experimental data, added additional statistical analyses, and provided specific information on the statistical methods used. We have quantified the results shown in Figure 2 (see point 4 below) and Figure 5F (point 6 below). The data shown in Figure 6 is intended to be qualitative, in showing mislocalization of rabies-labeled neurons in the *Hoxc8* SN mutant. The corresponding quantitative results, which required retrograde labeling of extensor MNs is shown in Figure 7C, E. We have clarified this in the revision. We have also revised our presentation of the data shown in Figure 7---figure supplement 2, and have limited our claims in the paper with respect to a pSN-MN "molecular matching" model (see point 7 below).

> 3\) The first few figures describe the expression of the Hox family factors in the dorsal root ganglia. This is important for setting up ideas on how they make function. However, as presented, it is not clear which Hox factors were actually assessed (it says Hox4-8-is this all clusters? Were some not looked at?) and what the characteristics are for each? The Materials and methods section doesn\'t help either because it just states the antibodies for the Hox factors have been described. This information needs to be more precise. We suggest a table summarizing all the Hox factors tested and a description of the characteristics would be valuable (supplement is fine). These should include the points made in the first few figures like is it expressed in DRG and does it overlap with markers of proprioceptive identity, what is the rostral caudal restriction if any, which Hox factors are co-expressed.

We thank the reviewers for this excellent suggestion and apologize for neglecting to include this important information. In the revision we have added a table indicating specifically which *Hox* genes were tested as well as those that were untested. We have included in this table: 1) whether the *Hox* protein is expressed in SNs, 2) its rostrocaudal domain of expression, and where possible, 3) whether any other *Hox* protein is coexpressed with the *Hox* protein under consideration (this is constrained by the host species of certain *Hox* antibodies).

We have also clarified in the main text that not all *Hox4-Hox8* paralog genes were analyzed. We have added precise information on the *Hox* antibody reagents used in the Key Resources Table.

> 4\) Limb bud removal experiments: In arguing for an autonomous Hox program in pSNs, this paper contradicts previous reports showing that muscle-derived cues specify pSN identity and connectivity with MNs. The key finding in the current paper supporting an intrinsic mechanism is the chick limb bud extirpation experiments in Figure 2 and Figure 2---figure supplement 1. However, the conclusions need to be better supported. While Figure 2I gives the sense that Hoxc8 expression is unaffected after limb bud removal, Figure 2---figure supplement 1C reveals that only a small fraction of Hoxc8-expressing neurons is in fact pSNs (this is different from mouse). If most of the Hoxc8-expressing sensory neurons are cutaneous, it is expected that they would be unaffected by removal of limb bud muscles. Figure 2---figure supplement 1C is thus the more important finding if it shows that the number of Hoxc8-expressing pSNs is unaffected after limb bud ablation. However, the number of Hoxc8^+^ Runx3^+^ neurons is small (2-3) in both images. More n\'s and quantification of Hox^+^Runx3^+^ neurons are needed to support the conclusion that pSN Hox expression is unaffected by removal of the limb bud.

In the revision we have quantified the fraction of all Isl1^+^ sensory neurons that express each of the three *Hox* proteins we analyzed in these experiments, both in controls and after forelimb ablation. We find that the fraction of SNs expressing *Hox* proteins is unchanged after limb bud ablation. However, consistent with recent studies (Wang et al., 2019), the number of SNs expressing the proprioceptive marker *Runx3* is reduced by \~50% (new Figure 2---figure supplement 1D)- making it difficult to assess the fraction of pSNs that maintain *Hox* expression. It has also been previously demonstrated that the pSN-class specific marker Er81 is markedly reduced after limb bud ablation (Lin et al., 1998). Nevertheless, while the fraction of SNs that express *Hoxc8* is relatively small in chick relative to mouse, we find that this percentage is unchanged after limb ablation (new Figure 2J-L). We added these results to main text as follows:

"The fraction of Isl1^+^ SNs expressing *Hoxa5* (44.3 ± 4.7% in controls, 50.7 ± 3.2% ablated, p=0.27, Student's t-test), *Hoxc6* (26.8 ± 2.0% controls, 26.3 ± 3.0% ablated, p=0.90), and *Hoxc8* (6.4 ± 0.9% controls, 7.6 ± 0.8% ablated, p=0.32) was not significantly changed (Figure 2J, K, L)."

We would also like to note that these ablation experiments not only remove limb muscle, but all limb-derived tissues (e.g. limb mesenchyme) that might provide instructive signals to both muscle and cutaneous SN subtypes. As the reviewers are likely aware, recently studies from the Ginty lab (Sharma et al., 2020) provide evidence that target-derived cues play important roles in specifying the transcriptional identity of both cutaneous and proprioceptive SNs. Thus, while *Hoxc8* is expressed by both cutaneous and proprioceptive SNs in chick, this pattern also appears to be target-independent.

We would also like to clarify that our study in no way contradicts the important role that target-derived cues play in pSN differentiation and connectivity. Our results provide evidence for a crucial limb-independent and *Hox*-dependent program that operates in conjunction with limb-dependent signaling programs. We have modified our Discussion to highlight this:

"While these results indicate a limb-independent mechanism of early neuronal differentiation, target-derived cues are *undoubtedly* required to establish the full molecular profile of pSNs and their functional characteristics."

> 5\) Figure 1---figure supplement 1A: schematizes Hox expression in DRGs along the rostro-caudal axis but the data only shows where the various Hox genes are expressed, not where they are not expressed, so we have to trust that the schematic accurately represents data that is not shown. All the rostro-caudal levels that are included in the schematic should be shown for all four Hox genes, as these authors did very beautifully in Catela et al., 2016 Figure 1.

The results in Figure 1I show a top-down view of *Hoxa5* and *Hoxc8* expression in DRG and spinal cord, which includes DRG that lack expression of these proteins. In the revision we have added top-down expression analyses for *Hoxc4*, *Hoxc6*, and *Hoxa7* in Figure 1---figure supplement 1A that similarly show the DRG lacking these proteins.

Unfortunately, we did not collect the negative *Hox* expression data for the serial sections shown in Figure 1---figure supplement 1A. Nevertheless, the data shown in Figure 1---figure supplement 1A were taken from a single embryo in which the relative rostrocaudal position for each section was recorded for each *Hox* antibody stain. Thus, the relative positioning of the rostrocaudal domains for *Hoxc4* and *Hoxc6* are accurate with respect to *Hoxa5* and *Hoxc8* in these panels, but only approximate relative to segmental level (i.e. C1-T1). We have clarified this in the figure legend, and indicate that similar results were obtained from a total of N=3 embryos analyzed at this stage.

> 6\) Figure 5E is an important figure showing that pSN identity is unaffected by conditional KO of Hoxc8. Rather than being presented as a single figure with three or four co-expressing neurons, this experiment should be done in Hoxc8 SN∆ mutants as quantitatively as the wildtype data presented in Figure 4.

We thank the reviewer for this suggestion. In the revision we have quantified the results from the retrograde tracing experiments and now present them in Figure 5F and the main text, as follows:

"We injected CTB into the FCU of *Hoxc8^SN∆^* mice at P4 and collected spinal cords with attached DRG at P7. We found that the fraction of pSNs that were βGal^+^ CTB^+^ was similar between controls and *Hoxc8^SN∆^*mice (65.19 ± 0.05% for N=4 control animals; 62.27 ± 0.08% for N=3 *Hoxc8^SN∆^*mice, p=0.75, Student's t-test) (Figure 5E, F)."

> 7\) Based on the finding in Figure 7 showing that Hoxc8 mutant pSNs inappropriately target extensor-innervating motor neurons, the authors conclude that a Hox matching mechanism required for synapse formation between pSNs and their appropriate MN targets has been disrupted. While this is an appealing possibility, other interpretations are equally possible. For instance, Hoxc8 may be important for the segregation of pSN axon subtypes in the sensory nerve, or for their axon guidance within the spinal cord. A prediction of the Hox matching mechanism is that flexor-innervating pSNs will fail to synapse on flexor-innervating MNs in Hoxc8 MN∆ animals and may inappropriately innervate extensor-innervating MNs. A single example of the latter result is shown (Figure 7---figure supplement 2D, E) -- more examples of this outcome would strengthen the Hox matching model.

In the revision, we have reworded our interpretation of these results, and only suggest a "matching model" as one possibility in the Discussion. We have also included other interpretations of the results as the reviewers have thoughtfully suggested. Unfortunately, due to technical constraints, we cannot perform the rabies-mediated transynaptic assays on the *Hoxc8* MN mutant, which would enable a more rigorous quantitative and definitive assessment of synaptic specificity deficits, as we were able to do with the SN-restricted knockout. We are also currently unable to repeat the synaptic tracing assay, due to the effects of the Covid19 shutdown on our mouse colony. We have therefore moved the *Hoxc8* MN mutant analysis from the main results to the Discussion, and explicitly state that analysis of *Hoxc8* MN mutants are preliminary and require additional supporting data. This section now reads as follows:

"Further studies will be necessary to definitively assess whether the coordinate regulation of MN and pSN connectivity by the same *Hox* gene contributes to sensory-motor specificity. \[...\] Although a *Hox*-specific molecular matching model for pSN-to-MN connectivity is provocative, *Hoxc8* could be required in pSNs, independent of *Hoxc8* in MN, for the segregation of axonal subtypes within the sensory nerve, or for their axon guidance within the spinal cord."

We believe the idea that *Hox* genes are needed in MNs during sensory-motor connectivity is additionally supported by the analyses of the *Hox* accessory factor *Foxp1* (Surmeli et al., 2011) and MN-*Hoxc9* mutants (Baek et al., 2017). We agree it remains to be determined whether there is an exact matching between muscle-specific pSNs and MN pools subtypes, but feel it is not an overstatement to say *Hox* genes are needed in both neuronal classes during sensory-motor circuit development.
